Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 12 of 12

List	Outcome	Time frame	Description
Primary	Change (%) From Baseline in Body Weight (Fasting)	Week 0, week 56	Weight was recorded to the nearest 0.1 kg for a subject in the fasting state with an empty bladder, without shoes and only wearing light clothing. The same calibrated scale was used throughout the trial.
Primary	Proportion of Subjects Losing at Least 5% of Baseline Body Weight	at 56 weeks	Weight was recorded to the nearest 0.1 kg for a subject in the fasting state with an empty bladder, without shoes and only wearing light clothing. The same calibrated scale was used throughout the trial.
Primary	Proportion of Subjects Losing More Than 10% of Baseline Body Weight	at 56 weeks	Weight was recorded to the nearest 0.1 kg for a subject in the fasting state with an empty bladder, without shoes and only wearing light clothing. The same calibrated scale was used throughout the trial.
Secondary	Change (%-Points) From Baseline in HbA1c (Glycosylated Haemoglobin A1c)	Week 0, week 56	Change in HbA1c (%-points) was calculated as the difference between the HbA1c (%) at Week 0 and Week 56.
Secondary	Proportion of Subjects Reaching Target HbA1c Below 7%	at 56 weeks
Secondary	Proportion of Subjects Reaching Target HbA1c Below or Equal to 6.5%	at 56 weeks
Secondary	Change From Baseline in Waist Circumference	Week 0, week 56
Secondary	Change (%) From Baseline in Body Weight (Fasting)	Week 0, week 68	Weight was recorded to the nearest 0.1 kg for a subject in the fasting state with an empty bladder, without shoes and only wearing light clothing. The same calibrated scale was used throughout the trial.
Secondary	Change (%) From Week 56 to 68 in Body Weight (Fasting)	Week 56, week 68	Weight was recorded to the nearest 0.1 kg for a subject in the fasting state with an empty bladder, without shoes and only wearing light clothing. The same calibrated scale was used throughout the trial.
Secondary	Change From Baseline in Waist Circumference	Week 0, week 68
Secondary	Change From Week 56 to 68 in Waist Circumference	Week 56, week 68
Secondary	Incidence of Hypoglycaemic Episodes	Weeks 0-56	Hypoglycaemic episodes were classified according to American Diabetes Association (ADA) definitions as well as to the Novo Nordisk definition of a minor hypoglycaemic event (blood glucose level below approximately 2.8 mmol/L \[50 mg/dL\] or plasma glucose level below 3.1 mmol/L \[56 mg/dL\]).

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01272232/registered

API reference For AI assistants